Sorbax Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Baddi, Himachal Pradesh, India, established in 2020.
2020 Baddi, Himachal Pradesh, India Active
Last Updated:
Access Report
About Sorbax Pharmaceuticals Private Limited

Sorbax Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 2020 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290HP2020PTC008140. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 13 professional, Its leadership includes Dheeraj Gangadhara Shetty (Director), Manjeet Kaur (Additional Director), Kota Suresh Prabhu (Director). Past directors included Krishan Chand Raghu. It holds ₹5.05 Cr open charges and ₹4.04 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.112-A, Hpsidc Industrial Estate Davni, Teh. Baddi, Distt. Solan, Baddi, Himachal Pradesh, 173205.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290HP2020PTC008140

  • Registration Number

    008140

  • Incorporation Date

    15 October 2020

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 5 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.05 Cr
  • Satisfied Charges ₹ 4.04 Cr
  • Revenue Growth **** 11661.87%
  • Profit Growth **** 108.11%
  • Ebitda **** 666.76%
  • Net Worth 171.45%
  • Total Assets **** 78.09%
Company report

Sorbax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sorbax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sorbax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dheeraj Gangadhara Shetty Director 24 Feb 2021 Current
Manjeet Kaur Additional Director 26 Apr 2024 Current
Kota Suresh Prabhu Director 15 Oct 2020 Current
Lalan Kumar Singh Director 15 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Mar 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sorbax Pharmaceuticals.

Sorbax Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11661.87% increase. The company also saw a substantial improvement in profitability, with a 108.11% increase in profit. The company's net worth Soared by an impressive increase of 171.45%.

Sorbax Pharmaceuticals revenue growth over time
Sorbax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 11661.87%
*******
*******
*******
*******
Revenue from Operations
*******
 11533.85%
*******
*******
*******
*******
Total Assets
*******
 78.09%
*******
*******
*******
*******
Profit or Loss
*******
 108.11%
*******
*******
*******
*******
Net Worth
*******
 171.45%
*******
*******
*******
*******
EBITDA
*******
 666.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sorbax Pharmaceuticals?

Unlock access to Sorbax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,500,000.00

Satisfied Charges

₹40,402,853.00

Charges Breakdown by Lending Institutions
  • Others : 5.05 Cr
Latest Charge Details
Date Lender Amount Status
27 Mar 2023 Others ₹5.05 Cr Open
13 Jul 2021 Karnataka Bank Ltd. ₹4.04 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sorbax Pharmaceuticals?

Unlock and access historical data on people associated with Sorbax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sorbax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sorbax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Sorbax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sorbax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh. was recorded as a recent event.

  • Director Appointment

    Manjeet Kaur was appointed as a Additional Director was appointed as a Additional Director on 26 Apr 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 13 Jul 2021 via Charge ID 100467096 with Karnataka Bank Ltd. was fully satisfied on 10 May 2023. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 5.05 Cr with Charge ID 100734512 was registered on 27 Mar 2023. was documented.

  • Charges

    A charge with Karnataka Bank Ltd. amounted to Rs. 4.04 Cr with Charge ID 100467096 was registered on 13 Jul 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sorbax Pharmaceuticals Private Limited?

The CIN of Sorbax Pharmaceuticals Private Limited is U24290HP2020PTC008140.

Where is Sorbax Pharmaceuticals Private Limited headquartered?

Sorbax Pharmaceuticals Private Limited is headquartered at Plot No.112-A, Hpsidc Industrial Estate Davni, Teh. Baddi, Distt. Solan, Baddi, Himachal Pradesh, 173205.

When was Sorbax Pharmaceuticals Private Limited incorporated?

Sorbax Pharmaceuticals Private Limited was incorporated on 15 October 2020.

Who are the current directors of Sorbax Pharmaceuticals Private Limited?

The current directors of Sorbax Pharmaceuticals Private Limited are

What is the primary industry of Sorbax Pharmaceuticals Private Limited?

The primary industry of Sorbax Pharmaceuticals Private Limited is Manufacturing.

Is Sorbax Pharmaceuticals Private Limited a listed company?

Sorbax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sorbax Pharmaceuticals Private Limited?

The authorized capital of Sorbax Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Sorbax Pharmaceuticals Private Limited?

The compliance status of Sorbax Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available